Precipio, Inc. (PRPO)
NASDAQ: PRPO · IEX Real-Time Price · USD
5.62
-0.13 (-2.26%)
May 1, 2024, 4:00 PM EDT - Market closed
Precipio Revenue
In the year 2023, Precipio had annual revenue of $15.20M with 61.46% growth. Revenue in the quarter ending December 31, 2023 was $4.33M with 81.05% year-over-year growth.
Revenue (ttm)
$15.20M
Revenue Growth
+61.46%
P/S Ratio
0.51
Revenue / Employee
$297,980
Employees
51
Market Cap
7.72M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.20M | 5.79M | 61.46% |
Dec 31, 2022 | 9.41M | 563.00K | 6.36% |
Dec 31, 2021 | 8.85M | 2.76M | 45.26% |
Dec 31, 2020 | 6.09M | 2.97M | 94.82% |
Dec 31, 2019 | 3.13M | 263.00K | 9.18% |
Dec 31, 2018 | 2.86M | 1.14M | 66.22% |
Dec 31, 2017 | 1.72M | -970.00K | -36.02% |
Dec 31, 2016 | 2.69M | 764.00K | 39.61% |
Dec 31, 2015 | 1.93M | 689.00K | 55.56% |
Dec 31, 2014 | 1.24M | -26.30M | -95.50% |
Dec 31, 2013 | 27.54M | -3.94M | -12.50% |
Dec 31, 2012 | 31.48M | -491.00K | -1.54% |
Dec 31, 2011 | 31.97M | 11.92M | 59.47% |
Dec 31, 2010 | 20.05M | -1.98M | -8.97% |
Dec 31, 2009 | 22.02M | -1.97M | -8.21% |
Dec 31, 2008 | 23.99M | 817.00K | 3.53% |
Dec 31, 2007 | 23.18M | -239.00K | -1.02% |
Dec 31, 2006 | 23.42M | -2.41M | -9.34% |
Dec 31, 2005 | 25.83M | 585.00K | 2.32% |
Dec 31, 2004 | 25.24M | -801.00K | -3.08% |
Dec 31, 2003 | 26.04M | -11.51M | -30.65% |
Dec 31, 2002 | 37.55M | -913.00K | -2.37% |
Dec 31, 2001 | 38.47M | 12.58M | 48.62% |
Dec 31, 2000 | 25.88M | 2.85M | 12.36% |
Dec 31, 1999 | 23.04M | 4.10M | 21.65% |
Dec 31, 1998 | 18.94M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Vivos Therapeutics | 13.80M |
Intelligent Bio Solutions | 2.88M |
Longeveron | 709.00K |
Notable Labs | 310.00K |
Kazia Therapeutics | 15.65K |
PRPO News
- 5 weeks ago - Precipio Announces Year end 2023 Shareholder Update Call - GlobeNewsWire
- 2 months ago - Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY - GlobeNewsWire
- 3 months ago - Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer - GlobeNewsWire
- 3 months ago - Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter - GlobeNewsWire
- 3 months ago - Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan - GlobeNewsWire
- 4 months ago - Precipio Announces Christina Valauri joins the Board of Directors - GlobeNewsWire
- 4 months ago - Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 - GlobeNewsWire
- 5 months ago - Precipio Announces Q3-2023 Shareholder Update Call - GlobeNewsWire